Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04050618 · ClinicalTrials.gov registry record · NA

Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
114
Enrollment target

NCT04050618: Completed NA study, sponsored by CooperVision.

NCT04050618 is a NA study that has completed, run by CooperVision. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04050618, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
114 participants
Enrollment target

Study Summary

To evaluate the comparative clinical performance of the fanfilcon A silicone hydrogel lens used in daily wear and to compare this with competitive hydrogel lens products.

Primary Outcome

Subjective overall comfort rating was assessed on a 0-10 subjective scale, 0=extremely uncomfortable, 10=can't feel lenses

Interventions

  • DEVICE fanfilcon A test lens
  • DEVICE ocufilcon D control lens
  • DEVICE etafilcon A control lens

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2019-06-09
Est. Completion 2019-11-08
Phase NA
CooperVision

64 total trials

What the finished NCT04050618 record still lists

NCT04050618 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 3 interventions - of which fanfilcon A test lens is the first listed.

NCT04050618 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04050618 about?

NCT04050618 is a clinical study titled "Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear". To evaluate the comparative clinical performance of the fanfilcon A silicone hydrogel lens used in daily wear and to compare this with competitive hydrogel lens products.

What is the current status of trial NCT04050618?

This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2019-06-09. Estimated completion is 2019-11-08.

What interventions are being tested in trial NCT04050618?

The interventions under investigation include: fanfilcon A test lens (DEVICE), ocufilcon D control lens (DEVICE), etafilcon A control lens (DEVICE).

Who is sponsoring clinical trial NCT04050618?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04050618's enrollment target sits among peer trials

114 811th of 2000 higher than 1,188 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04522791 · 114 participants · Phase 2

    Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

  • NCT04875052 · 114 participants · NA

    Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury

  • NCT05100342 · 114 participants

    Prospective Validation of a Points Score System Predicting 30-day Survival

  • NCT05224089 · 114 participants · Phase 4

    Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04050618, the US trial registry maintained by the National Library of Medicine. NCT04050618 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.